New Hampshire House Bill 701 establishes the Terminal Patients' Right to Try Act, creating legal pathways for terminally ill patients to access experimental treatments, including regenerative therapies, that have not yet received full FDA approval.
This act recognizes the fundamental right of terminal patients to make informed decisions about their medical care, including access to experimental treatments that may offer hope when conventional options have been exhausted.
- Legal protection for physicians providing experimental treatments
- Patient eligibility criteria for accessing experimental therapies
- Informed consent requirements and documentation standards
- Insurance and liability protections for healthcare providers
Research Details
Cite this article: New Hampshire Legislature. "New Hampshire HB701 - Expanded Right to Try Act". Published August 21, 2025. Available at: https://www.billtrack50.com/billdetail/1794175
Access Original Research
View the complete study and detailed methodology from the original source.
Read Full Study↗
